Literature DB >> 16469394

Late postnatal onset of hearing loss due to GJB2 mutations.

Waheeda Pagarkar1, Maria Bitner-Glindzicz, Jeffrey Knight, Tony Sirimanna.   

Abstract

GJB2 mutations account for approximately 50% of recessive non-syndromic deafness, with 35delG being the most prevalent. Homozygous 35delG mutations cause pre-lingual, non-progressive hearing loss that is detected on newborn hearing screening programmes. We present a sibling pair with homozygous 35delG mutations, who passed hearing tests in early infancy and developed progressive sensorineural hearing loss, one requiring a cochlear implant. These cases illustrate that deafness due to such mutations may have a late onset and consequently be missed on neonatal screening programmes and they may present an argument to consider neonatal screening for GJB2 mutations in order to aid early intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469394     DOI: 10.1016/j.ijporl.2005.10.026

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  9 in total

1.  A case-control study on high-risk factors for newborn hearing loss in seven cities of Shandong province.

Authors:  Wenying Nie; Hanrong Wu; Yisheng Qi; Qian Lin; Lili Xiang; Hui Li; Yinghui Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

2.  Concurrent Hearing and Genetic Screening of 180,469 Neonates with Follow-up in Beijing, China.

Authors:  Pu Dai; Li-Hui Huang; Guo-Jian Wang; Xue Gao; Chun-Yan Qu; Xiao-Wei Chen; Fu-Rong Ma; Jie Zhang; Wan-Li Xing; Shu-Yan Xi; Bin-Rong Ma; Ying Pan; Xiao-Hua Cheng; Hong Duan; Yong-Yi Yuan; Li-Ping Zhao; Liang Chang; Ru-Zhen Gao; Hai-Hong Liu; Wei Zhang; Sha-Sha Huang; Dong-Yang Kang; Wei Liang; Ke Zhang; Hong Jiang; Yong-Li Guo; Yi Zhou; Wan-Xia Zhang; Fan Lyu; Ying-Nan Jin; Zhen Zhou; Hong-Li Lu; Xin Zhang; Ping Liu; Jia Ke; Jin-Sheng Hao; Hai-Meng Huang; Di Jiang; Xin Ni; Mo Long; Luo Zhang; Jie Qiao; Cynthia Casson Morton; Xue-Zhong Liu; Jing Cheng; De-Min Han
Journal:  Am J Hum Genet       Date:  2019-09-26       Impact factor: 11.025

3.  Bilingualism: A Pearl to Overcome Certain Perils of Cochlear Implants.

Authors:  Tom Humphries; Poorna Kushalnagar; Gaurav Mathur; Donna Jo Napoli; Carol Padden; Christian Rathmann; Scott Smith
Journal:  J Med Speech Lang Pathol       Date:  2014

Review 4.  Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.

Authors:  Emilie Hoang Dinh; Shoeb Ahmad; Qing Chang; Wenxue Tang; Benjamin Stong; Xi Lin
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

5.  Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss.

Authors:  Margaret A Kenna; Henry A Feldman; Marilyn W Neault; Anna Frangulov; Bai-Lin Wu; Brian Fligor; Heidi L Rehm
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-01

6.  Language acquisition for deaf children: Reducing the harms of zero tolerance to the use of alternative approaches.

Authors:  Tom Humphries; Poorna Kushalnagar; Gaurav Mathur; Donna Jo Napoli; Carol Padden; Christian Rathmann; Scott R Smith
Journal:  Harm Reduct J       Date:  2012-04-02

7.  Residual Hearing in DFNB1 Deafness and Its Clinical Implication in a Korean Population.

Authors:  So Young Kim; Ah Reum Kim; Kyu Hee Han; Min Young Kim; Eun-Hee Jeon; Ja-Won Koo; Seung Ha Oh; Byung Yoon Choi
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

8.  Phenotypic Heterogeneity of Post-lingual and/or Milder Hearing Loss for the Patients With the GJB2 c.235delC Homozygous Mutation.

Authors:  Hongyang Wang; Yun Gao; Jing Guan; Lan Lan; Ju Yang; Wenping Xiong; Cui Zhao; Linyi Xie; Lan Yu; Dayong Wang; Qiuju Wang
Journal:  Front Cell Dev Biol       Date:  2021-02-26

9.  EMQN Best Practice guidelines for diagnostic testing of mutations causing non-syndromic hearing impairment at the DFNB1 locus.

Authors:  Lies H Hoefsloot; Anne-Françoise Roux; Maria Bitner-Glindzicz
Journal:  Eur J Hum Genet       Date:  2013-05-22       Impact factor: 4.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.